R-Biopharm is a leading developer of test solutions for Clinical Diagnostics and Food & Feed Analysis. In both sectors, the R-Biopharm test kits offer high precision and accuracy, key requirements where patient and consumer health is at risk.
R-Biopharm AG was founded in 1988 as a subsidiary of Röhm GmbH in Darmstadt, Germany. In 1991 it was taken over by the present chairman of the board, Dr. Ralf M. Dreher. Since 1996 R-Biopharms quality management systems have been certified to the international standards ISO 9001 and in 2003 the company gained ISO 13485 quality management certification. From January 2000 R-Biopharm acquired sole worldwide distribution rights to Enzymatic BioAnalysis, a product developed by Roche (formerly BOEHRINGER Mannheim). In 2002 R-Biopharm took over Rhône Diagnostics Technologies in Scotland, another supplier of mycotoxin test kits, resulting in successful expansion of its position in the food and feed analysis sector. Today the German parent company R-Biopharm is represented by subsidiaries in the USA, UK, Italy, France, Latin America, Brazil, Spain, Belgium, Australia, India, China and the Netherlands, as well as by a worldwide extensive network of more than 120 distributors. In addition, Switzerland and Austria are represented by local Country Managers.
In Clinical Diagnostics, R-Biopharm possesses many years of experience, particularly in the field of infectious stool diagnostics as well as in the field of serological infection diagnostics and allergy diagnostics. R-Biopharm has been a successful player worldwide and is constantly developing new and groundbreaking test systems in different areas.
Food & Feed Analysis
In the field of Food & Feed Analysis, R-Biopharm offers an impressive range of immunological, enzymatic and microbiological test kits for the detection of residues, constituents and contaminants. The use of R-Biopharm kits to detect mycotoxins, hormones, antibiotics, food allergens, genetically modified organisms and pathogens is fast, reliable and cost effective.
With its own division “Nutrition Care”, R-Biopharm develops innovative concepts for complementary therapies to improve patients quality of life. The special diagnostics and customizable programs and services are optimally tuned to one another to find the ideal nutrition and to improve prevention, therapy and wellbeing.
In the field of Clinical Diagnostics as well as in the field of Food & Feed Analysis, the products have been designed and developed primarily for immunoassay platforms. Nonetheless, there is also a great emphasis on other test formats such as PCR, lateral flow, immunoblots, immunofluorescence assays, immunoaffinity columns or card tests. RIDASCREEN®, RIDA®, PREP®, EASI EXTRACT, and PentoCheck® were worldwide recognized trademarks of R-Biopharm.
R-Biopharm has earned high accolades for its business performance. In 2004, the company achieved a double success, being nominated as a finalist for “Entrepreneur of the Year” 2004, 2005 and 2006 as well as being placed in 2004 and 2005 in the “Technology Fast 50”, a ranking of Germanys 50 fastest-growing technology companies. Moreover, R-Biopharm received the “Sustainability Award” in the years 2012, 2013 and 2014.